Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0086543 (
cataract
)
29,165
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Alzheimer's disease (AD) and age-related
cataract
, disorders characterized by protein aggregation causing late-onset disease, both involve oxidative stress. We hypothesize that common variants of
NFE2L2
and KEAP1, the genes encoding the main regulators of the Nrf2 system, an important defence system against oxidative stress, may influence risk of AD and/or age-related
cataract
. This case-control study combines an AD material (725 cases and 845 controls), and a
cataract
material (489 cases and 182 controls). Genetic variation in
NFE2L2
and KEAP1 was tagged by eight and three tag single nucleotide polymorphisms (SNPs), respectively. Single SNPs and haplotypes were analyzed for associations with disease risk, age parameters, MMSE and AD cerebrospinal fluid biomarkers.
NFE2L2
and KEAP1 were not associated with risk of AD or
cataract
. However, one haplotype allele of
NFE2L2
was associated with 2 years earlier age at AD onset (p(c)=0.013) and 4 years earlier age at surgery for posterior subcapsular
cataract
(p(c)=0.019). Another haplotype of
NFE2L2
was associated with 4 years later age at surgery for cortical
cataract
(p(c)=0.009). Our findings do not support
NFE2L2
or KEAP1 as susceptibility genes for AD or
cataract
. However, common variants of the
NFE2L2
gene may affect disease progression, potentially altering clinically recognized disease onset.
...
PMID:Nrf2-encoding NFE2L2 haplotypes influence disease progression but not risk in Alzheimer's disease and age-related cataract. 2006 47